• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压门诊中的继发性高血压

Secondary hypertension in a blood pressure clinic.

作者信息

Sinclair A M, Isles C G, Brown I, Cameron H, Murray G D, Robertson J W

出版信息

Arch Intern Med. 1987 Jul;147(7):1289-93.

PMID:3606286
Abstract

The prevalence, reversibility, and mortality of secondary hypertension among 3783 patients with moderately severe nonmalignant hypertension attending the Glasgow (Scotland) Blood Pressure Clinic were assessed. Underlying causes of hypertension were found in 297 patients (7.9%). Eighty-seven patients (2.3%) were considered to have a potentially reversible cause for their hypertension, including the oral contraceptive pill (38 patients), renovascular disease (27 patients), and primary hyperaldosteronism (ten patients), but of these only 33 patients (0.9% of total clinic population) were cured by specific intervention. Two hundred ten patients (5.6%) had irreversible renal parenchymal disease and significantly higher mortality than men and women with other causes of hypertension. Excess deaths in the renal group were attributed to renal failure (International Classification of Diseases [ICD] 580 to 589) and vascular causes (ICD 390 to 458) but not to cancer (ICD 140 to 208; 235 to 239) or other nonvascular disease. These results suggest that investigation of hypertension for an underlying cause will reveal a small number of patients with treatable disorders, of whom only a few will be cured by specific intervention, and a moderate number with irreversible disease who are at high risk of myocardial infarction and stroke.

摘要

对格拉斯哥(苏格兰)血压诊所的3783例中度严重非恶性高血压患者的继发性高血压患病率、可逆性及死亡率进行了评估。在297例患者(7.9%)中发现了高血压的潜在病因。87例患者(2.3%)被认为其高血压存在潜在可逆病因,包括口服避孕药(38例)、肾血管疾病(27例)及原发性醛固酮增多症(10例),但其中只有33例患者(占诊所总人数的0.9%)通过特异性干预得以治愈。210例患者(5.6%)患有不可逆性肾实质疾病,其死亡率显著高于患有其他高血压病因的男性和女性。肾病组的额外死亡归因于肾衰竭(国际疾病分类[ICD]580至589)和血管性病因(ICD 390至458),而非癌症(ICD 140至208;235至239)或其他非血管性疾病。这些结果表明,对高血压潜在病因进行调查将发现少数患有可治疗疾病的患者,其中只有少数患者能通过特异性干预治愈,还有相当数量患有不可逆疾病的患者,他们发生心肌梗死和中风的风险很高。

相似文献

1
Secondary hypertension in a blood pressure clinic.血压门诊中的继发性高血压
Arch Intern Med. 1987 Jul;147(7):1289-93.
2
[Primary and secondary hypertension in polyclinical patients].[综合临床患者中的原发性和继发性高血压]
Schweiz Med Wochenschr. 1977 Apr 30;107(17):605-9.
3
[Primary and secondary hypertension. Review of hospital cases].[原发性和继发性高血压。医院病例综述]
Boll Soc Ital Cardiol. 1977;22(8):1449-53.
4
Reno-ureteral diseases inducing hypertension in children.
Rom J Intern Med. 2008;46(4):367-74.
5
[Arterial hypertension in patients on chronic hemodialysis].[慢性血液透析患者的动脉高血压]
Srp Arh Celok Lek. 1996 Sep-Oct;124(9-10):246-50.
6
A profile of renal/renovascular abnormalities in patients of hypertension.高血压患者的肾脏/肾血管异常概况。
J Indian Med Assoc. 2002 Jun;100(6):363-4, 366-8.
7
[The incidence of raised blood pressure with specific causes (secondary hypertension)].[特定病因(继发性高血压)导致的血压升高发生率]
Ugeskr Laeger. 1975 Jan 27;137(5):245-8.
8
Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program.高血压检测与随访项目中可治愈高血压的表观患病率。
Arch Intern Med. 1985 Mar;145(3):424-7.
9
[Renovascular hypertension--clinical observations and long-term follow-up].
Przegl Lek. 1994;51(7):285-90.
10
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.2004年加拿大高血压教育计划关于高血压管理的建议:第一部分——血压测量、诊断及风险评估
Can J Cardiol. 2004 Jan;20(1):31-40.

引用本文的文献

1
Functional paraganglioma of the pancreatic head: A case report and review of literature.胰头功能性副神经节瘤:一例报告并文献复习
World J Gastrointest Surg. 2025 Jul 27;17(7):105833. doi: 10.4240/wjgs.v17.i7.105833.
2
Ambulatory blood pressure monitoring before and after resection of catecholamine-secreting pheochromocytoma or paraganglioma.切除分泌儿茶酚胺的嗜铬细胞瘤或副神经节瘤前后的动态血压监测
J Hum Hypertens. 2025 May;39(5):369-375. doi: 10.1038/s41371-025-01008-6. Epub 2025 Mar 26.
3
Hypertension and Cushing's syndrome: hunt for the red flag.
高血压与库欣综合征:寻找警示信号。
J Endocrinol Invest. 2025 Mar 18. doi: 10.1007/s40618-024-02453-9.
4
SWEET'S SYNDROME ASSOCIATED WITH PHEOCHROMOCYTOMA: A RARE CASE REPORT AND REVIEW OF LITERATURE.伴发嗜铬细胞瘤的斯威特综合征:1例罕见病例报告及文献复习
Acta Endocrinol (Buchar). 2024 Apr-Jun;20(2):222-230. doi: 10.4183/aeb.2024.222. Epub 2025 Jan 18.
5
Hypertension in chronic kidney disease: What lies behind the scene.慢性肾脏病中的高血压:幕后真相
Front Pharmacol. 2022 Oct 11;13:949260. doi: 10.3389/fphar.2022.949260. eCollection 2022.
6
Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.青紫型和非青紫型先天性心脏病患者血浆代谢产物的比较。
Endocrine. 2022 Dec;78(3):580-586. doi: 10.1007/s12020-022-03205-6. Epub 2022 Oct 4.
7
Primary Aldosteronism: State-of-the-Art Review.原发性醛固酮增多症:最新研究综述。
Am J Hypertens. 2022 Dec 8;35(12):967-988. doi: 10.1093/ajh/hpac079.
8
Cardiogenic Shock With Reverse Takotsubo Pattern Secondary to Pheochromocytoma: A Case Report.嗜铬细胞瘤继发反向性Takotsubo型心源性休克:一例报告
Cureus. 2021 Nov 15;13(11):e19600. doi: 10.7759/cureus.19600. eCollection 2021 Nov.
9
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.COVID-19 导致肾损伤的机制和当前的药物治疗方法。
Inflamm Res. 2022 Jan;71(1):39-56. doi: 10.1007/s00011-021-01520-8. Epub 2021 Nov 21.
10
A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective.一家中心 15 年嗜铬细胞瘤和副神经节瘤诊治经验:新加坡视角。
Singapore Med J. 2022 Nov;63(11):649-658. doi: 10.11622/smedj.2021135. Epub 2021 Oct 4.